Study Ever (NAPSA)—To follow up on two promising earlier studies, the National Cancer Institute is sponsoring a study to determine if selenium and vitamin E can protect against prostate cancer. The study, called SELECT, will include a total of 32,400 men. A prostate cancerpreventiontrial is now underway and seeking men 55 years or olderto participate. After skin cancer, prostate can- cer is the most commontypeof cancer in men. In the U.S. alone, prostate cancerwill be diagnosed in about 198,100 menthis year. All men are at risk, but those at highest risk fall into one or moreof the following categories: 55 years orolder, African American, or have a father or brother with prostate cancer. Participants in the study must be 55 years or older (50 for African Americans), in good health and have no history of prostate cancer. More information about the study is available by visiting http://cancer.gov/select or calling the National Cancer Institute at 1-800-4-CANCER.
